Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions (Q39737595)

14 September 2017

Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions (English)

1 reference

14 September 2017

Markus Schwaiger

10

0 references

Ernst J. Rummeny

8

object named as

Ernst J Rummeny

1 reference

14 September 2017

3

Michael Souvatzoglou

1 reference

14 September 2017

9

Sibylle Ziegler

1 reference

14 September 2017

2

Axel Martinez-Möller

1 reference

14 September 2017

11

Stephan G Nekolla

1 reference

14 September 2017

Matthias Eiber

1

1 reference

14 September 2017

Konstantin Holzapfel

4

1 reference

14 September 2017

Anja Pickhard

5

1 reference

14 September 2017

Dennys Löffelbein

6

1 reference

14 September 2017

Ivan Santi

7

1 reference

14 September 2017

Ambros J Beer

12

1 reference

14 September 2017

18 June 2011

1 reference

14 September 2017

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

14 September 2017

38

1 reference

14 September 2017

9

1 reference

14 September 2017

1691-1701

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-011-1842-9

14 September 2017

0 references

cites work

Combined PET/MRI: a new dimension in whole-body oncology imaging?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Whole-body PET/MRI: the future in oncological imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Multiple myeloma: clinical review and diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Metabolic and molecular imaging in neuro-oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Whole-body MRI and PET-CT in the management of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Whole-body MR imaging: evaluation of patients for metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Radionuclide and hybrid imaging of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

X-ray-based attenuation correction for positron emission tomography/computed tomography scanners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Magnetic resonance imaging-guided attenuation and scatter corrections in three-dimensional brain positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Three-region MRI-based whole-body attenuation correction for automated PET reconstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Emerging techniques: whole-body screening and staging with MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

21 January 2018

MRI of bone metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Lymph node metastases: CT and MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Imaging of lymphadenopathy in the neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

MRI of the lung: value of different turbo spin-echo, single-shot turbo spin-echo, and 3D gradient-echo pulse sequences for the detection of pulmonary metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

The effects of incomplete breath-holding on 3D MR Image Quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1842-9

Simultaneous PET/MR will replace PET/CT as the molecular multimodality imaging platform of choice

21 January 2018

1 reference

12 December 2020

HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT

1 reference

12 December 2020

Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging

1 reference

12 December 2020

Is MR-guided attenuation correction a viable option for dual-modality PET/MR imaging?

1 reference

12 December 2020

Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions.

1 reference

12 December 2020

10.1007/S00259-011-1842-9

Identifiers

DOI

1 reference

14 September 2017

1 reference